11-hydroxy-delta(9)-tetrahydrocannabinol and raclopride

11-hydroxy-delta(9)-tetrahydrocannabinol has been researched along with raclopride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boellaard, R; Bossong, MG; Kahn, RS; Lammertsma, AA; Ramsey, NF; Schuit, RC; van Berckel, BN; van Gerven, JM; Windhorst, AD; Zuurman, L	1

Trials

1 trial(s) available for 11-hydroxy-delta(9)-tetrahydrocannabinol and raclopride

Article	Year
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3 Topics: Administration, Inhalation; Adult; Cannabinoid Receptor Modulators; Corpus Striatum; Cross-Over Studies; Dopamine; Double-Blind Method; Dronabinol; Heart Rate; Humans; Magnetic Resonance Imaging; Male; Placebos; Positron-Emission Tomography; Psychiatric Status Rating Scales; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3	2009

Article

Year

Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3

Topics: Administration, Inhalation; Adult; Cannabinoid Receptor Modulators; Corpus Striatum; Cross-Over Studies; Dopamine; Double-Blind Method; Dronabinol; Heart Rate; Humans; Magnetic Resonance Imaging; Male; Placebos; Positron-Emission Tomography; Psychiatric Status Rating Scales; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3

2009